Oligonucleotide synthesis refers to the chemical synthesis of short sequences of DNA or RNA oligonucleotides. Oligonucleotides are short sequences of nucleic acids that are widely used in molecular biology, diagnostics, therapeutics and research. They find applications as probes for detection of DNA or RNA sequences, in gene expression profiling, as antisense oligos to control gene expression and as primers in polymerase chain reaction. The advantages of oligonucleotide synthesis include high specificity and affinity towards complementary nucleic acid sequences. The growing need for oligonucleotides in drug development and discovery, especially for nucleic acid-based therapeutics and personalized medicines is driving significant growth of this market.
The Global Oligonucleotide Synthesis Market is estimated to be valued at US$ 4565 Bn in 2024 and is expected to exhibit a CAGR of 13.% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the Oligonucleotide Synthesis are Forte Research Systems (India), ICON plc (Ireland), Merge healthcare incorporated (U.S.), Bio-Optronics (U.S.), DSG INC (U.S.), ArisGlobal (India), ERT Clinical Bioclinica (U.S.), Oracle Corporation (U.S.), Medidata Solutions (U.S.), DATATRAK International, Inc. (U.S.), and MedNet Solutions, Inc., (U.S.). The demand for oligonucleotides is growing significantly due to increase in drug discovery activities and number of clinical trials conducted annually. Advancements in oligonucleotide chemistries and synthesis technologies such as solid phase synthesis have improved the efficiency and yield of oligonucleotide production.
Market Trends
Custom oligonucleotide synthesis Market Size And Trends services are gaining popularity as they provide flexible, rapid and cost-effective solutions. Next generation sequencing techniques use oligonucleotides extensively and are driving increased consumption. Emergence of new oligonucleotide therapeutics such as antisense oligonucleotides, siRNAs, and oligonucleotide conjugates is a key trend in this market.
Market Opportunities
Personalized medicine relying on biomarkers, especially for oncology indications provides major opportunities. Continued growth in clinical trials globally requiring patient recruitment and data collection supports market expansion. Emerging economies with large patient bases and growing biomedical research present significant untapped potential over the coming years.
Impact of COVID-19 on Oligonucleotide Synthesis Market Growth
The outbreak of COVID-19 has impacted the oligonucleotide synthesis market significantly. In the initial months of the pandemic, research activities slowed down due to lockdowns and social distancing measures. This led to a decline in demand for custom oligonucleotides required for research. However, with the focus shifting towards developing diagnostics, vaccines and therapies for COVID-19, the demand for oligonucleotides increased rapidly. Several research laboratories and pharma companies ramped up nucleic acid synthesis efforts to screen drug candidates and develop PCR based diagnostic kits for SARS-CoV-2 virus detection. With the accelerated development of COVID-19 related applications, the oligonucleotide synthesis market is expected to grow steadily in the post pandemic period. Companies are now well prepared with pandemic response plans and high production capacities to cater to any surge in demand for oligonucleotides. Continued focus on vaccine development, virus variance tracking and pandemic preparedness are likely to drive sustained growth of this market going forward.
Geographical Regions with high Oligonucleotide Synthesis Market Concentration
In terms of value, North America holds the largest share of the global Oligonucleotide Synthesis Market Size, followed by Europe. This is due to presence of major pharmaceutical and biotechnology companies and research institutions conducting R&D activities involving oligonucleotides. The United States represents the largest market in the North America region. The Asia Pacific region has emerged as the fastest growing market for oligonucleotide synthesis in recent years. Countries like China and India are witnessing rising investments in healthcare and life sciences sectors. This has increased the demand for custom oligonucleotides from biotechnology and pharmaceutical startups developing therapies and diagnostics for diseases like cancer. Latin America and Middle East & Africa also present lucrative opportunities for market players to expand in emerging markets.
Fastest Growing Region in the Oligonucleotide Synthesis Market
The Asia Pacific region is poised to be the fastest growing market for oligonucleotide synthesis globally. Factors such as rapid economic development, heavy investments in biomedical research, growing healthcare expenditure, rising incidence of chronic diseases and development of local capabilities are driving the demand for oligonucleotides in Asia Pacific countries. China stands out as a major contributor to the oligonucleotide synthesis market growth in this region. It is estimated that the market size in China will double in the next five years owing to focus on developing generic drugs and biologics local manufacturing through initiatives like Made In China 2025. Other Asia Pacific nations like India, South Korea and Singapore are also experiencing an increase in oligonucleotide based drug development efforts, which will influence the regional market growth in the coming years.
Get More Insights oligonucleotide synthesis Market
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)